Business Context and Reporting Period
Company: The Clorox Company
Filing Type: Form 8-K (Current Report)
Date of Report: August 28, 2015
Subject: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Item 5.03)
Financial Metrics
This filing does not contain financial performance data. Revenue, profit, cash flow, margins, debt, and liquidity metrics are not reported in this document.
Material Changes
The Board of Directors amended and restated the Company's Bylaws, effective August 28, 2015. Key changes include:
- Proxy Access: Implementation of Article I, Section 10A, permitting a stockholder or group of up to 20 stockholders owning 3% or more of outstanding common stock continuously for at least three years to nominate directors constituting up to 20% of the Board.
- Exclusive Forum: Addition of a new Section 8 in Article VII designating Delaware as the sole and exclusive forum for certain legal actions unless the Company consents otherwise.
- Disclosure Requirements: Amendments to Article I, Section 10 requiring specific disclosures for stockholder-nominated individuals and fees/interests held by proposing stockholders.
- Notice Periods: Revision of notice periods for stockholder proposals if the annual meeting date shifts from the previous year's anniversary.
Guidance, Outlook, and Risks
This filing does not provide financial guidance, outlook, or management commentary on operational performance. The primary risk context relates to corporate governance changes, specifically the new exclusive forum provision for legal actions and the expanded rights for stockholder director nominations.
Key Facts for Investor Verification
- Verify the specific eligibility criteria for proxy access nominations (3% ownership for 3 years).
- Review the full text of the Amended and Restated Bylaws (Exhibit 3.2) for detailed legal definitions.
- Confirm the scope of legal actions subject to the Delaware exclusive forum provision.
- Note that this filing is a governance update and does not reflect changes in financial condition.